高级检索
当前位置: 首页 > 详情页

Tannic acid activates the Kv7.4 and Kv7.3/7.5 K+ channels expressed in HEK293 cells and reduces tension in the rat mesenteric arteries

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Univ Chinese Med, Dept Pharmacol, 3 Xingyuan Rd, Shijiazhuang 050200, Hebei, Peoples R China [2]Hebei Med Univ, Hosp 4, Dept Pharm, Shijiazhuang, Peoples R China [3]Maternal & Child Hlth Hosp, Dept Pharm, Tangshan, Peoples R China [4]Hebei Med Univ, Hosp 2, East Branch, Vasc Surg, Shijiazhuang, Hebei, Peoples R China [5]Air Force Gen Hosp, Intens Care Unit, Beijing, Peoples R China [6]China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China
出处:
ISSN:

关键词: antihypertension K+ channels tannic acid vascular tension

摘要:
ObjectivesThis study investigated the effect of tannic acid (TA), a plant-derived hydrolyzable polyphenol, on Kv7.4 and Kv7.5 K+ channels and rat mesenteric artery. MethodsWhole-cell patch clamp experiments were used to record the Kv7.4 and Kv7.3/7.5 K+ currents expressed in HEK293 cells; and the tension changes of mesenteric arteries isolated from rats were recorded using small vessel myography apparatus. Key findingsTannic acid increases the Kv7.4 and Kv7.3/7.5 K+ currents in a concentration-dependent manner (median effective concentration (EC50) = 27.3 3.6 m and EC50 = 23.1 +/- 3.9 m, respectively). In addition, 30 m TA shifts the G-V curve of Kv7.4 and Kv7.3/7.5 K+ currents to the left by 14.18 and 25.24 mV, respectively, and prolongs the deactivation time constants by 184.44 and 154.77 ms, respectively. Moreover, TA relaxes the vascular tension of rat mesenteric arteries in a concentration-dependent manner (half inhibitory concentration (IC50) = 148.7 +/- 13.4 m). ConclusionThese results confirms the vasodilatory effects of TA on rat mesenteric artery and the activating effects on the Kv7.4 and Kv7.3/7.5 K+ channels, which may be a mechanism to explain the vasodilatory effect and this mechanism can be used in the research of antihypertension.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 3 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 药学
JCR分区:
出版当年[2016]版:
Q3 PHARMACOLOGY & PHARMACY
最新[2024]版:
Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2024版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Hebei Univ Chinese Med, Dept Pharmacol, 3 Xingyuan Rd, Shijiazhuang 050200, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Hebei Univ Chinese Med, Dept Pharmacol, 3 Xingyuan Rd, Shijiazhuang 050200, Hebei, Peoples R China [*1]Department of Pharmacology, Hebei University of Chinese Medicine, No. 3, Xingyuan Road, Shijiazhuang 050200, Hebei, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号